- October 1, 2013
Serial NC team eyes another deal with latest biotech - June 13, 2013
Aerial Biopharma Wins Triangle Business Journal’s Best Early-Stage Development Company - June 7, 2013
Chattanooga Investment Firm, After Selling 2 Prior Businesses, Develops New Sleep Treatment - June 5, 2013
ADX-NO5 Results Presented at SLEEP 2013 Meeting
-
We are a different kind of drug development company.
Aerial BioPharma is a group of entrepreneurs who have come together to change the way investors and industry think about drug development. Aerial is a privately held biopharmaceutical company focused on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded in January of 2011 by the management team from Neuronex Inc. and Addrenex Pharmaceuticals, both successful start-ups based in the Research Triangle Park area of North Carolina.
Read More
"Our approach is to rapidly bring innovative drugs to market to improve patients’ lives and enable our investors to achieve a positive return."
Dr. Moise Khayrallah, Chief Executive Officer & Co-Founder
Partners
With a successful history of partnering, the leadership team from Aerial Biopharma has current partnering opportunities in Narcolepsy, Pain Management, and Nausea/Vomiting
Investors
Led by a management team with a successful track record, Aerial Biopharma is currently focused on the development of compounds for Narcolepsy, Pain and Nausea/Vomiting. Primarily backed by Angel investors, Aerial is currently raising its second tranche of a $12 million dollar investment.